To investigate a role for IFN-γ in the control of SCC, mice with established SCC tumours were injected with an anti-IFN-γ neutralising antibody or an isotype control antibody at the same time as TAC-diet withdrawal (Figure 3A). This evidence concerns the gene IFNG and neoplasm.